Technical Analysis for CELC - Celcuity Inc.

Grade Last Price % Change Price Change
grade F 11.23 3.03% 0.33
CELC closed up 3.03 percent on Friday, January 17, 2020, on 57 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical CELC trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Inside Day Range Contraction 0.00%
50 DMA Resistance Bearish 3.03%
20 DMA Support Bullish 3.03%
Wide Range Bar Range Expansion 3.03%
Doji - Bearish? Reversal 3.03%
Upper Bollinger Band Touch Strength 3.03%
Bearish Engulfing Bearish 5.45%
20 DMA Support Bullish 5.45%
50 DMA Resistance Bearish 0.63%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Celcuity, Inc. is a United States-based early stage biotechnology company. The Company develops tests that functionally analyze diseased live cells. The Company has developed CELx Pathway Profile technology, which combines advancements in primary tissue research with a method of measuring a targeted therapy's functional pathway effect on live and diseased patient cells. The Company offers functional cellular analysis platform that assesses the functionality of the disease-related signaling pathways of patient's diseased cells ex vivo and determines whether a drug therapy has the effect on diseased cells. The Company's CELx test is designed to determine whether a pathway is functional to therapeutic intervention without regard to the exact mechanism a patient's tumor may have developed to resist the therapeutic effect. The Company’s diagnostic approach helps to identify cancer subtypes.
Biotechnology Cancer Biology Stem Cells Cell Biology Cell Signaling Signal Transduction Drug Therapy Systems Biology Patient's Tumor

Is CELC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.0
52 Week Low 8.91
Average Volume 15,033
200-Day Moving Average 17.76
50-Day Moving Average 11.09
20-Day Moving Average 10.63
10-Day Moving Average 10.95
Average True Range 0.78
ADX 22.31
+DI 26.14
-DI 21.29
Chandelier Exit (Long, 3 ATRs ) 10.37
Chandelier Exit (Short, 3 ATRs ) 11.46
Upper Bollinger Band 11.83
Lower Bollinger Band 9.44
Percent B (%b) 0.75
BandWidth 22.52
MACD Line -0.01
MACD Signal Line -0.12
MACD Histogram 0.1098
Fundamentals Value
Market Cap 109.18 Million
Num Shares 9.72 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -561.50
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.40
Resistance 3 (R3) 12.44 12.10 12.21
Resistance 2 (R2) 12.10 11.80 12.08 12.14
Resistance 1 (R1) 11.66 11.61 11.88 11.62 12.07
Pivot Point 11.32 11.32 11.43 11.30 11.32
Support 1 (S1) 10.88 11.02 11.10 10.84 10.39
Support 2 (S2) 10.54 10.83 10.52 10.32
Support 3 (S3) 10.10 10.54 10.26
Support 4 (S4) 10.06